GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » COSMOS Pharmaceutical Corp (OTCPK:CSMYF) » Definitions » Change In Receivables

COSMOS Pharmaceutical (COSMOS Pharmaceutical) Change In Receivables : $0 Mil (TTM As of Feb. 2024)


View and export this data going back to 2014. Start your Free Trial

What is COSMOS Pharmaceutical Change In Receivables?

COSMOS Pharmaceutical's change in receivables for the quarter that ended in Feb. 2024 was $0 Mil. It means COSMOS Pharmaceutical's Accounts Receivable stayed the same from Nov. 2023 to Feb. 2024 .

COSMOS Pharmaceutical's change in receivables for the fiscal year that ended in May. 2023 was $-12 Mil. It means COSMOS Pharmaceutical's Accounts Receivable increased by $12 Mil from May. 2022 to May. 2023 .

COSMOS Pharmaceutical's Accounts Receivable for the quarter that ended in Feb. 2024 was $4 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. COSMOS Pharmaceutical's Days Sales Outstanding for the three months ended in Feb. 2024 was 0.22.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. COSMOS Pharmaceutical's liquidation value for the three months ended in Feb. 2024 was $-975 Mil.


COSMOS Pharmaceutical Change In Receivables Historical Data

The historical data trend for COSMOS Pharmaceutical's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

COSMOS Pharmaceutical Change In Receivables Chart

COSMOS Pharmaceutical Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.32 -2.11 -6.78 -14.75 -12.40

COSMOS Pharmaceutical Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

COSMOS Pharmaceutical Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


COSMOS Pharmaceutical  (OTCPK:CSMYF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

COSMOS Pharmaceutical's Days Sales Outstanding for the quarter that ended in Feb. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=3.79/1596.638*91
=0.22

2. In Ben Graham's calculation of liquidation value, COSMOS Pharmaceutical's accounts receivable are only considered to be worth 75% of book value:

COSMOS Pharmaceutical's liquidation value for the quarter that ended in Feb. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=123.317-1376.6+0.75 * 3.79+0.5 * 551.489
=-975

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


COSMOS Pharmaceutical Change In Receivables Related Terms

Thank you for viewing the detailed overview of COSMOS Pharmaceutical's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


COSMOS Pharmaceutical (COSMOS Pharmaceutical) Business Description

Traded in Other Exchanges
Address
4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, JPN, 812-0013
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.

COSMOS Pharmaceutical (COSMOS Pharmaceutical) Headlines

From GuruFocus

Matthews Japan Fund Reduces Stake in COSMOS

By Kyle Ferguson Kyle Ferguson 08-12-2016

Hennessy Japan Small Cap Fund Adds 5 Stocks to Portfolio

By Sydnee Gatewood Sydnee Gatewood 01-10-2020